|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wagner M, Redaelli C, Lietz M, Seiler CA,
Friess H and Buchler MW: Curative resection is the single most
important factor determining outcome in patients with pancreatic
adenocarcinoma. Br J Surg. 91:586–594. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yadav D and Lowenfels AB: The epidemiology
of pancreatitis and pancreatic cancer. Gastroenterology.
144:1252–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beger HG, Thorab FC, Liu Z, Harada N and
Rau BM: Pathogenesis and treatment of neoplastic diseases of the
papilla of Vater: Kausch-Whipple procedure with lymph node
dissection in cancer of the papilla of Vater. J Hepatobiliary
Pancreat Surg. 11:232–238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schultz NA, Andersen KK, Roslind A,
Willenbrock H, Wøjdemann M and Johansen JS: Prognostic microRNAs in
cancer tissue from patients operated for pancreatic cancer-five
microRNAs in a prognostic index. World J Surg. 36:2699–2707. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu L, Xiang L, Feng J, Li B, Zhou Z, Li J,
Lin Y, Lv Y, Zou D, Lei Z and Zhang J: miRNA-21 and miRNA-223
expression signature as a predictor for lymph node metastasis,
distant metastasis and survival in kidney renal clear cell
carcinoma. J Cancer. 9:3651–3659. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin Y, Lv Y, Liang R, Yuan C and Zhang J,
He D, Zheng X and Zhang J: Four-miRNA signature as a prognostic
tool for lung adenocarcinoma. Onco Targets Ther. 11:29–36. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wiemer EA: The role of microRNAs in
cancer: No small matter. Eur J Cancer. 43:1529–1544. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bak RO and Mikkelsen JG: miRNA sponges:
Soaking up miRNAs for regulation of gene expression. Wiley
Interdiscip Rev RNA. 5:317–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duell EJ, Lujan-Barroso L, Sala N, Deitz
McElyea S, Overvad K, Tjonneland A, Olsen A, Weiderpass E, Busund
LT, Moi L, et al: Plasma microRNAs as biomarkers of pancreatic
cancer risk in a prospective cohort study. Int J Cancer.
141:905–915. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Namkung J, Kwon W, Choi Y, Yi SG, Han S,
Kang MJ, Kim SW, Park T and Jang JY: Molecular subtypes of
pancreatic cancer based on miRNA expression profiles have
independent prognostic value. J Gastroenterol Hepatol.
31:1160–1167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee KH, Lee JK, Choi DW, Do IG, Sohn I,
Jang KT, Jung SH, Heo JS, Choi SH and Lee KT: Postoperative
prognosis prediction of pancreatic cancer with seven microRNAs.
Pancreas. 44:764–768. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goldman M, Craft B, Hastie M, Repečka K,
Kamath A, McDade F, Rogers D, Brooks AN, Zhu J and Haussler D: The
UCSC Xena platform for public and private cancer genomics data
visualization and interpretation. bioRxiv. 3264702019.
|
|
18
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie M, Lv Y, Liu Z, Zhang J, Liang C, Liao
X, Liang R, Lin Y and Li Y: Identification and validation of a
four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p)
prognosis signature in clear cell renal cell carcinoma. Cancer
Manag Res. 10:5759–5766. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu TT, Chen YF, Hastie T, Sobel E and
Lange K: Genome-wide association analysis by lasso penalized
logistic regression. Bioinformatics. 25:714–721. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tibshirani R: The lasso method for
variable selection in the Cox model. Stat Med. 16:385–395. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin Z, Cai YJ, Chen RC, Chen BC, Zhao L,
Xu SH, Wang XD, Song M, Wu JM, Wang YQ, et al: A microRNA
expression profile for vascular invasion can predict overall
survival in hepatocellular carcinoma. Clin Chim Acta. 469:171–179.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heagerty PJ, Lumley T and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan Y, Siklenka K, Arora SK, Ribeiro P,
Kimmins S and Xia J: miRNet-dissecting miRNA-target interactions
and functional associations through network-based visual analysis.
Nucleic Acids Res. 44:W135–W141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Demchak B, Hull T, Reich M, Liefeld T,
Smoot M, Ideker T and Mesirov JP: Cytoscape: The network
visualization tool for GenomeSpace workflows. F1000Res. 3:1512014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen
X, Zhang Q, Yan G and Cui Q: LncRNADisease: A database for
long-non-coding RNA-associated diseases. Nucleic Acids Res.
41:D983–D986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tavano F, di Mola FF, Piepoli A, Panza A,
Copetti M, Burbaci FP, Latiano T, Pellegrini F, Maiello E,
Andriulli A and di Sebastiano P: Changes in miR-143 and miR-21
expression and clinicopathological correlations in pancreatic
cancers. Pancreas. 41:1280–1284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giovannetti E, van der Velde A, Funel N,
Vasile E, Perrone V, Leon LG, De Lio N, Avan A, Caponi S, Pollina
LE, et al: High-throughput microRNA (miRNAs) arrays unravel the
prognostic role of MiR-211 in pancreatic cancer. PLoS One.
7:e491452012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gurbuz N and Ozpolat B: MicroRNA-based
targeted therapeutics in pancreatic cancer. Anticancer Res.
39:529–532. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chiaravalli M, Reni M and O'Reilly EM:
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new
therapeutic strategies. Cancer Treat Rev. 60:32–43. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang L, Wei DM, Li JJ, Luo DZ, Chen G,
Dang YW and Cai XY: Prognostic microRNAs and their potential
molecular mechanism in pancreatic cancer: A study based on The
Cancer Genome Atlas and bioinformatics investigation. Mol Med Rep.
17:939–951. 2018.PubMed/NCBI
|
|
34
|
Yu Y, Feng X and Cang S: A two-microRNA
signature as a diagnostic and prognostic marker of pancreatic
adenocarcinoma. Cancer Manag Res. 10:1507–1515. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou X, Huang Z, Xu L, Zhu M, Zhang L,
Zhang H, Wang X, Li H, Zhu W, Shu Y and Liu P: A panel of 13-miRNA
signature as a potential biomarker for predicting survival in
pancreatic cancer. Oncotarget. 7:69616–69624. 2016.PubMed/NCBI
|
|
36
|
Dou D, Yang S, Lin Y and Zhang J: An
eight-miRNA signature expression-based risk scoring system for
prediction of survival in pancreatic adenocarcinoma. Cancer
Biomark. 23:79–93. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pai P, Rachagani S, Are C and Batra SK:
Prospects of miRNA-based therapy for pancreatic cancer. Curr Drug
Targets. 14:1101–1109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Principe DR, DeCant B, Mascariñas E, Wayne
EA, Diaz AM, Akagi N, Hwang R, Pasche B, Dawson DW, Fang D, et al:
TGFβ signaling in the pancreatic tumor microenvironment promotes
fibrosis and immune evasion to facilitate tumorigenesis. Cancer
Res. 76:2525–2539. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu K, Hu G, He X, Zhou P, Li J, He B and
Sun W: MicroRNA-424-5p suppresses the expression of SOCS6 in
pancreatic cancer. Pathol Oncol Res. 19:739–748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ma J, Zhang J, Weng YC and Wang JC:
EZH2-mediated microRNA-139-5p regulates epithelial-mesenchymal
transition and lymph node metastasis of pancreatic cancer. Mol
Cells. 41:868–880. 2018.PubMed/NCBI
|
|
41
|
Ku JL, Yoon KA, Kim WH, Jang Y, Suh KS,
Kim SW, Park YH and Park JG: Establishment and characterization of
four human pancreatic carcinoma cell lines. Genetic alterations in
the TGFBR2 gene but not in the MADH4 gene. Cell Tissue Res.
308:205–214. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li D, Yang W, Zhang Y, Yang JY, Guan R, Xu
D and Yang MQ: Genomic analyses based on pulmonary adenocarcinoma
in situ reveal early lung cancer signature. BMC Med Genomics. 11
(Suppl 5):S1062018. View Article : Google Scholar
|
|
44
|
Gao X, Chen Y, Chen M, Wang S, Wen X and
Zhang S: Identification of key candidate genes and biological
pathways in bladder cancer. PeerJ. 6:e60362018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yeh MH, Tzeng YJ, Fu TY, You JJ, Chang HT,
Ger LP and Tsai KW: Extracellular matrix-receptor interaction
signaling genes associated with inferior breast cancer survival.
Anticancer Res. 38:4593–4605. 2018. View Article : Google Scholar : PubMed/NCBI
|
